| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0264-410X(02)00454-1 |
| P698 | PubMed publication ID | 12450708 |
| P2093 | author name string | Muhammad Hasan | |
| Thomas G Evans | |||
| Dania Caron | |||
| Laurent Galibert | |||
| P2860 | cites work | Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination of healthy adults | Q73175525 |
| FLT3 ligand induces the generation of functionally active dendritic cells in mice | Q73618306 | ||
| Hepatitis B immunization of healthy elderly adults: relationship between naïve CD4+ T cells and primary immune response and evaluation of GM-CSF as an adjuvant | Q73803218 | ||
| Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but notCD11b(low)CD11c(high) murine dendritic cells in vivo: a comparative analysis with Flt3 ligand | Q73910703 | ||
| Prediction of response to hepatitis B vaccine in health care workers: whose titers of antibody to hepatitis B surface antigen should be determined after a three-dose series, and what are the implications in terms of cost-effectiveness? | Q74388947 | ||
| Reciprocal control of T helper cell and dendritic cell differentiation | Q74452751 | ||
| Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group | Q28241816 | ||
| Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells | Q28285435 | ||
| Immunobiology of dendritic cells | Q29547465 | ||
| Prevention of peripheral tolerance by a dendritic cell growth factor: flt3 ligand as an adjuvant | Q33368912 | ||
| Dendritic cells: therapeutic potentials | Q33579423 | ||
| Polyomavirus-infected dendritic cells induce antiviral CD8(+) T lymphocytes | Q33803386 | ||
| Experimentally induced recruitment of plasmacytoid (CD123high) dendritic cells in human nasal allergy | Q33921703 | ||
| Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid | Q34332534 | ||
| Adjuvants for human vaccines--current status, problems and future prospects | Q34373525 | ||
| Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified | Q36367631 | ||
| Clinical experience with hepatitis B vaccines | Q38656202 | ||
| Present status of the use of cytokines as adjuvants with vaccines to protect against infectious diseases | Q41072146 | ||
| Dramatic numerical increase of functionally mature dendritic cells in FLT3 ligand-treated mice. | Q41586707 | ||
| Induction of dendritic cells (DC) by Flt3 Ligand (FL) promotes the generation of tumor-specific immune responses in vivo. | Q41674781 | ||
| The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand | Q42012073 | ||
| Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo | Q45193405 | ||
| P433 | issue | 3-4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 322-329 | |
| P577 | publication date | 2002-12-01 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | The use of Flt3 ligand as an adjuvant for hepatitis B vaccination of healthy adults | |
| P478 | volume | 21 |
| Q38417265 | Advances and challenges in mucosal adjuvant technology |
| Q81205526 | CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study |
| Q34453827 | Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients |
| Q56790230 | Evaluation of the effects of human leukocyte IFN-α on the immune response to the HBV vaccine in healthy unvaccinated individuals |
| Q45874543 | Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization |
| Q36899084 | Improving vaccines by incorporating immunological coadjuvants |
| Q35862144 | Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial. |
| Q35826412 | Modulating vaccine responses with dendritic cells and Toll-like receptors |
| Q40464391 | Murine mammary adenocarcinoma cells transfected with p53 and/or Flt3L induce antitumor immune responses. |
| Q36150499 | Progress in drug development of immunostimulatory CpG oligodeoxynucleotide ligands for TLR9. |
| Q81690459 | PyNTTTTGT prototype oligonucleotide IMT504 is a potent adjuvant for the recombinant hepatitis B vaccine that enhances the Th1 response |
| Q64377294 | Spleen but not tumor infiltration by dendritic and T cells is increased by intravenous adenovirus-Flt3 ligand injection |
Search more.